Silencing of FAM46C expression in primary gastric cancer was found to be a biomarker for metastasis or recurrence16, and gene knockdown in hepatocellular carcinoma suppressed the anti-metastatic effects of norcantharidin17. Here, TENT5C is linked to gastric cancer.